All peptides
ImmuneResearch Phase

Beta-Defensin 2

Topical, Subcutaneous injection
Written by Peptide Association Editorial TeamMedically reviewed by Ian Justl Ellis, MD, CPTLast reviewed Editorial policy

Overview

Beta-defensin 2 (hBD-2) is an antimicrobial peptide of approximately 40 amino acids produced by epithelial cells in response to infection or inflammation. It disrupts microbial membranes and also functions as a chemoattractant for immune cells via CCR6 receptor binding.

Mechanism of Action

Therapeutic interest includes infection control and immune adjuvant applications.

Research Summary & Key Findings

Preclinical studies have confirmed broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses, along with immunomodulatory properties. Clinical development of recombinant or synthetic beta-defensin 2 for topical or systemic use remains in early phases, with no advanced trials or approvals reported.

Clinical Status

Research Phase

Beta-Defensin 2 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

TopicalSubcutaneous injection

References

Primary literature

Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.

Related Peptides in Immune

Start Your Consultation

Get an AI-proposed Beta-Defensin 2 protocol reviewed by a physician in our network.

Start Your Consultation

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Beta-Defensin 2.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.